Bank of New York Mellon Corp — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Bank of New York Mellon Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.08B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $18.62B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $17.70B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $16.53B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $15.93B | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $15.81B | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $16.46B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $16.39B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $15.54B | Feb 27, 2020 |
| FY2015 | Dec 31, 2015 | $15.13B | Feb 26, 2016 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.55B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $4.53B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $3.30B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $2.56B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $3.76B | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $3.62B | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $4.44B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $4.27B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $4.09B | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $3.55B | Feb 27, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.73B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $687.00M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $5.91B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $15.07B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $2.84B | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $5.04B | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $96.00M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $6.00B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $4.67B | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $6.27B | Feb 27, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.55B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $1.47B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $1.22B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $1.35B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $1.22B | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $1.22B | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $1.21B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $1.11B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $1.20B | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $825.00M | Feb 27, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $472.30B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $416.06B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $409.88B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $405.56B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $444.44B | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $469.63B | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $381.51B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $362.87B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $371.76B | Feb 27, 2020 |
| FY2017 | Dec 31, 2016 | $333.47B | Feb 28, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $427.49B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $374.30B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $368.97B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $364.93B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $401.05B | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $423.51B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $339.78B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $322.01B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $330.01B | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $293.89B | Feb 28, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $44.31B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $41.32B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $40.77B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $40.73B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $43.03B | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $45.80B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $41.48B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $40.64B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $41.25B | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $38.81B | Feb 28, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.77B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $16.60B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $16.26B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $16.15B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $17.51B | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $17.50B | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $17.39B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $17.35B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $17.56B | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $17.32B | Feb 27, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $46.40B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $42.54B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $39.55B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $37.86B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $36.67B | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $34.24B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $31.89B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $28.65B | Feb 27, 2020 |
| FY2018 | Jan 1, 2018 | $25.58B | Feb 27, 2019 |
| FY2018 | Dec 31, 2017 | $25.64B | Feb 27, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.11B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $4.18B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $4.92B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $5.03B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $6.06B | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $6.25B | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $4.83B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $5.86B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $5.38B | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $4.82B | Feb 27, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $31.87B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $30.85B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $31.26B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $30.46B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $25.93B | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $25.98B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $27.50B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $29.16B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $27.98B | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $24.46B | Feb 28, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7 | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 5 | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | 3 | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 4 | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | 3 | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | 4 | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | 4 | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | 3 | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | 3 | Feb 27, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7 | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 5 | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | 3 | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 4 | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | 3 | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | 4 | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | 4 | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | 3 | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | 3 | Feb 27, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 688.24M | Feb 25, 2026 |
| FY2024 | Dec 31, 2024 | 717.68M | Feb 27, 2025 |
| FY2023 | Dec 31, 2023 | 759.34M | Feb 28, 2024 |
| FY2022 | Dec 31, 2022 | 808.44M | Feb 27, 2023 |
| FY2021 | Dec 31, 2021 | 804.15M | Feb 25, 2022 |
| FY2020 | Dec 31, 2020 | 886.76M | Feb 25, 2021 |
| FY2019 | Dec 31, 2019 | 900.68M | Feb 27, 2020 |
| FY2018 | Dec 31, 2018 | 960.43M | Feb 27, 2019 |
| FY2017 | Dec 31, 2017 | 1.01B | Feb 28, 2018 |
| FY2016 | Dec 31, 2016 | 1.05B | Feb 28, 2017 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.45B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $1.35B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $1.26B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $1.17B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $1.13B | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $1.12B | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $1.12B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $1.05B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $901.00M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $778.00M | Feb 27, 2019 |